Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 13:27:07 26/06/2024 BST			5-day change	1st Jan Change
25.94 ^EUR	-0.81%		-0.63%	-22.76%

01:58pm	Anton switch to Dortmund perfect? Voller rows back	DP
07:16am	Bayer CEO - Making faster progress with restructuring	RE

Bayer to Launch Ten Blockbuster Agriculture Products in the Next Decade

June 17, 2024 at 01:41 pm

By Helena Smolak

Bayer plans to launch ten blockbuster agriculture products in the next 10 years, generating over 5 billion euros ($5.35 billion) in sales.

The German biotechnology company said Monday, during its 2024 Crop Science innovation update in Chicago, that it expects each product to contribute to more than 500 million euros to its more than EUR32 billion peak sales potential in its research and development pipeline.

Write to Helena Smolak at helena.smolak@wsj.com

(END) Dow Jones Newswires

06-17-24 0840ET

Latest news about Bayer AG

Anton switch to Dortmund perfect? Voller rows back	12:58pm	DP
Bayer CEO - Making faster progress with restructuring	06:16am	RE
Chemical industry wage partners seek solution before the end of the peace period	04:51am	DP
Bayer: patients recruited for phase 2 Parkinson's trial	06-25	CF
Bayer and Solynta Collaborate to Advance True Potato Seed in Smallholder Markets	06-24	CI
Global markets live: Vodafone, Bayer, Apple, Microsoft, Qualcomm...	06-19
Bayer's Crop Science Business Developing AI to Kill Weeds	06-19	MT
Bayer looks to AI to combat herbicide resistance faster	06-18	RE
Transcript : Bayer Aktiengesellschaft - Special Call	06-18
New Bayer short corn variety stands up to high winds, but not over 100 mph	06-18	RE
South Africa finds high prices, lack of competition in its fresh produce market	06-18	RE
Economics Minister Habeck travels to China without prominent company representatives	06-18	RE
Alvotech Enters Commercialization Deal for Eylea Biosimilars with Advanz Pharma	06-18	MT
Nationwide actions - Trade union increases pressure in chemical industry collective bargaining round	06-18	DP
German economy minister's China trip features low-key business delegation amid EV clash	06-18	RE
BAYER : Berenberg remains 'hold', target 30 euros	06-17	CF
Bayer Targets 10 Blockbuster Product Launches for Crop Sciences	06-17	MT
Bayer has more confidence in its agricultural pipeline thanks to new products	06-17	RE
Bayer: ten 'blockbusters' expected in crop protection	06-17	CF
Bayer to Launch Ten Blockbuster Agriculture Products in the Next Decade	06-17	DJ
Berenberg rates Bayer a 'Hold' - Target 30 euros	06-17	DP
BAYER AG : Berenberg remains Neutral	06-17	ZD
BAYER AG : Barclays sticks Neutral	06-17	ZD
Restrictions on glyphosate remain in place	06-14	DP
Archer-Daniels-Midland, Bayer to Expand Regenerative Agriculture Program to Eastern Europe	06-13	MT

Chart Bayer AG

Duration

Period

More charts

Company Profile

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).

Sector

Pharmaceuticals

Calendar

06/08/2024 - Q2 2024 Earnings Release

Related indices

Euro STOXX 50 Index , STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

BAYER : As soft as anticipated

May 14, 2024 at 07:12 pm

Bayer AG: Not out of the woods yet

March 06, 2024 at 03:46 pm

More Strategies

Ratings for Bayer AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

26.15 EUR

Average target price

36.18 EUR

Spread / Average Target

+38.36%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BAYER AG	-22.76%	27.5B
ELI LILLY AND COMPANY	+55.19%	815B
NOVO NORDISK A/S	+45.77%	654B
JOHNSON & JOHNSON	-6.09%	354B
MERCK & CO., INC.	+21.92%	337B
ABBVIE INC.	+10.18%	302B
ASTRAZENECA PLC	+18.38%	247B
ROCHE HOLDING AG	+2.66%	229B
NOVARTIS AG	+13.34%	219B
AMGEN INC.	+10.86%	171B

Other Pharmaceuticals

Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Bayer to Launch Ten Blockbuster Agriculture Products in the Next Decade

EPS Revisions